| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(99)80065-8 |
| P698 | PubMed publication ID | 10068099 |
| P2093 | author name string | Alvarez E | |
| Alvarez F | |||
| Ciocca M | |||
| Cuarterolo M | |||
| Ramonet M | |||
| Cañero-Velasco C | |||
| Drut R | |||
| Brochu P | |||
| Camarena C | |||
| Gonzalez T | |||
| de Davila MT | |||
| Jara-Vega P | |||
| P2860 | cites work | Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents | Q72333198 |
| Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis | Q72768073 | ||
| Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin | Q41204289 | ||
| Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis | Q43225448 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset | Q49173574 | ||
| Autoimmune hepatitis in childhood: a 20-year experience. | Q53361457 | ||
| Autoimmune Hepatitis | Q54248463 | ||
| Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis | Q67743320 | ||
| Liver disease associated with anti-liver-kidney microsome antibody in children | Q70019464 | ||
| Meeting report: International Autoimmune Hepatitis Group | Q70496892 | ||
| Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients | Q70855460 | ||
| Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis | Q72039839 | ||
| P433 | issue | 2 | |
| P921 | main subject | cyclosporine | Q367700 |
| autoimmune hepatitis | Q786844 | ||
| P304 | page(s) | 222-227 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Short-term cyclosporine induces a remission of autoimmune hepatitis in children. | |
| P478 | volume | 30 |
| Q34715356 | APS-I/APECED: the clinical disease and therapy |
| Q38000056 | Advances in the current treatment of autoimmune hepatitis |
| Q34100094 | An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood |
| Q43904331 | Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs |
| Q33870268 | Autoimmune hepatitis |
| Q73922527 | Autoimmune hepatitis |
| Q74528656 | Autoimmune hepatitis |
| Q84019041 | Autoimmune hepatitis |
| Q86954391 | Autoimmune hepatitis |
| Q34661366 | Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance |
| Q78631174 | Autoimmune hepatitis and overlap syndromes |
| Q37957350 | Autoimmune hepatitis from the paediatric perspective |
| Q34936578 | Autoimmune hepatitis in children |
| Q80054493 | Autoimmune hepatitis in children |
| Q37754771 | Autoimmune hepatitis in children: diagnosis, pathology and treatment |
| Q33342074 | Autoimmune hepatitis, from mechanisms to therapy |
| Q60932817 | Autoimmune hepatitis: Appraisal of current treatment guidelines |
| Q42358509 | Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments |
| Q77721792 | Autoimmune liver disease |
| Q37058457 | Autoimmune liver disease: news and perspectives |
| Q26766699 | Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver |
| Q36376398 | Cost-effectiveness of pharmacotherapy for autoimmune hepatitis |
| Q34490185 | Current and novel immunosuppressive therapy for autoimmune hepatitis |
| Q38222882 | Current and prospective pharmacotherapy for autoimmune hepatitis |
| Q38609184 | Current concepts in the diagnosis and management of autoimmune hepatitis |
| Q34615157 | Current therapy for autoimmune hepatitis |
| Q43645960 | Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis |
| Q37708360 | Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis: Interim Analysis Report of a Randomized Controlled Trial |
| Q46449483 | De novo autoimmune hepatitis following liver transplantation: a case report |
| Q28076505 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q36501745 | Do we need alternative treatment options for autoimmune hepatitis? |
| Q38051706 | Drug choices in autoimmune hepatitis: part B--Nonsteroids |
| Q44728174 | Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. |
| Q33947177 | End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. |
| Q34936778 | Evolving new therapies of autoimmune hepatitis |
| Q80720176 | Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease |
| Q34609672 | Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report |
| Q82207909 | Immunosuppressive Therapy Allows Recovery From Liver Failure in Children With Autoimmune Hepatitis |
| Q38930837 | Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. |
| Q37559266 | Immunosuppressive therapy in immune-mediated liver disease in the non-transplanted patient |
| Q33948215 | Juvenile autoimmune hepatitis: Spectrum of the disease |
| Q40441464 | Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. |
| Q34426395 | Long-term immunosuppression and drug interactions |
| Q35621266 | Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis |
| Q26859099 | Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids |
| Q36379083 | Management of patients with difficult autoimmune hepatitis |
| Q33447479 | Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. |
| Q90734771 | Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis |
| Q37607111 | Novel Immunotherapies for Autoimmune Hepatitis. |
| Q38133924 | Paediatric autoimmune liver disease |
| Q37828507 | Pharmacological management of autoimmune hepatitis |
| Q37558805 | Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A. |
| Q46966926 | Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids |
| Q38175465 | Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis |
| Q34369116 | Review article: autoimmune hepatitis -- current management and challenges. |
| Q35030822 | Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis |
| Q38027909 | Review article: overlap syndromes and autoimmune liver disease |
| Q26864272 | Review article: the management of autoimmune hepatitis beyond consensus guidelines |
| Q37139335 | The use of budesonide in the treatment of autoimmune hepatitis in Canada |
| Q35099092 | Transition of care between paediatric and adult gastroenterology. Autoimmune hepatitis |
| Q36029429 | Treatment challenges and investigational opportunities in autoimmune hepatitis |
| Q40485481 | Treatment of Autoimmune Hepatitis: Current and Future Therapies |
| Q34149523 | Treatment of autoimmune hepatitis: A review of current and evolving therapies |
| Q34342199 | Treatment of autoimmune liver disease: current and future therapeutic options |
| Q34936764 | Treatment strategies in autoimmune hepatitis |
| Q22305505 | Update on autoimmune hepatitis |
| Q82734860 | [Current trend: autoimmune hepatitis] |
Search more.